Skip to Main Content

Paper Details

Early phase clinical studies of AR-42, a histone deacetylase inhibitor, for neurofibromatosis type 2-associated vestibular schwannomas and meningiomas.
Laryngoscope Investig Otolaryngol
11
2021
Author NameAffiliation
Craig C HofmeisterDepartment of Hematology & Oncology Winship Cancer Institute of Emory University Atlanta Georgia USA.
Jaishri O Blakeley& Oncology Johns Hopkins University Baltimore Maryland USA.
  • 1 - 2

Datasets

Release 1.2